why choose us

First received: November 11, 2022

Clinical Trial: Early Intestinal Ultrasound in Predicting Treatment Response to Filgotinib in Ulcerative Colitis

Study Status: Active, not recruiting

Recruit Status: Active, not recruiting

Condition: Ulcerative Colitis

Study Type: Observational


Official Title: Intestinal Ultrasonography in Ulcerative Colitis Patients Treated With Filgotinib

Brief Summary: Objective disease assessment in inflammatory bowel diseases at the time of treatment initiation and during follow-up has become gold standard. However, biomarkers, such as C-reactive protein and fecal calprotectin, fail to provide information on disease extent, location or complications. Repeated endoscopic assessments are performed to evaluate mucosal response to treatment, though associated costs, availability, invasiveness and patient preference are considerable limitations. Recently, intestinal ultrasound…

Read more